Regeneron Pharmaceuticals (0R2M.L) Stock Price
$549.6 0.8%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
6 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Regeneron Pharmaceuticals, AI stock picks, stock alerts and much more.
0R2M.L AI Stock Analysis
AI stock analysis for 0R2M.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Regeneron Pharmaceuticals (0R2M.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Regeneron Pharmaceuticals (0R2M.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Regeneron Pharmaceuticals (0R2M.L), currently trading at $549.6, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0R2M.L
-
Regeneron Pharmaceuticals, Inc.
-
Symbol
0R2M.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
58.3B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$460 1.1% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$129.4 0.4% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$7.03 2.4% |
4 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.84 2.4% |
5 |
 |
Walgreens Boots Alliance 0LSZ.L |
$11.45 0.2% |
4 |
News
0R2M.L Alternative Data
Web Traffic
Regeneron Pharmaceuticals receives an estimated 319793 monthly visitors to regeneron.com.
-
Web Traffic
319793
-
Change from Previous Month
16.6%
-
3 Month Change
10.1%
-
YoY Change
10.1%
Twitter Followers
Regeneron Pharmaceuticals has 33,259 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.6% over the last month.
-
Twitter Followers
33259
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
0.9%
-
YoY Change
0.9%
TikTok Followers
Regeneron Pharmaceuticals has 2,169 TikTok Followers on its main TikTok account, down by -0.6% over the last month.
-
TikTok Followers
2169
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
1.5%
Facebook Engagement
Regeneron Pharmaceuticals has engaged 1,124 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
1124
-
Daily Change
11%
-
1 Month Change
28.5%
-
3 Month Change
51.2%
-
YoY Change
51.2%
Instagram Followers
Regeneron Pharmaceuticals has 16,460 Instagram Followers on its main Instagram account, up by 3.2% over the last month.
-
Instagram Followers
16460
-
Daily Change
0%
-
1 Month Change
3.2%
-
3 Month Change
12.9%
-
YoY Change
12.9%
Youtube Subscribers
Regeneron Pharmaceuticals has 2,310 subscribers on its main Youtube channel, up by 3.1% over the last month.
-
Youtube Subscribers
2310
-
Daily Change
0%
-
1 Month Change
3.1%
-
3 Month Change
6%
Job Postings
Regeneron Pharmaceuticals currenly has an estimated 308 open job postings, up by 3.7% over the last month.
-
Job Postings
308
-
Daily Change
2%
-
1 Month Change
3.7%
-
3 Month Change
3.1%
-
YoY Change
3.1%
Reddit Mentions
Regeneron Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
LinkedIn Followers
552,849 are following Regeneron Pharmaceuticals on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
552849
-
Daily Change
1.6%
-
1 Month Change
1.6%
-
3 Month Change
4%
-
YoY Change
4%
Business Outlook
According to employee reviews, the business outlook among employees at Regeneron Pharmaceuticals is 71 out of 100 (bullish), down by -1.4% over the last month.
-
Business Outlook
71
-
Change from Previous Month
1.4%
-
3 Month Change
6.6%
-
YoY Change
6.6%
LinkedIn Employees
According to LinkedIn, Regeneron Pharmaceuticals has 16,240 employees, up by 1.7% over the last month.
-
LinkedIn Employees
16240
-
Daily Change
1.7%
-
1 Month Change
1.7%
-
3 Month Change
2.8%
-
YoY Change
2.8%
News Mentions
Regeneron Pharmaceuticals was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
50%
-
YoY Change
50%
0R2M.L Financials
0R2M.L Key Metrics
-
Total Revenue
$3B
-
Net Income
$808.7M
-
Earnings per Share
$7.58
-
Free cash flow
$773.6M
-
EBITDA
$1B
-
EBITDA Ratio
0.34358
-
Total Assets
$37.5B
0R2M.L 2-year Revenue & Income
0R2M.L 2-year Free Cash Flow
0R2M.L Technicals
0R2M.L SMA
0R2M.L RSI
FAQ
What's the current price of Regeneron Pharmaceuticals (0R2M.L) Stock?
The price of an Regeneron Pharmaceuticals (0R2M.L) share is $549.6.
What's the market cap of Regeneron Pharmaceuticals?
The current market cap of Regeneron Pharmaceuticals is 58.3B.
Should I buy or sell 0R2M.L?
Regeneron Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Regeneron Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Regeneron Pharmaceuticals a good investment?
The current analysis of Regeneron Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Regeneron Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Regeneron Pharmaceuticals (0R2M.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Regeneron Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Regeneron Pharmaceuticals (0R2M.L) that investors often compare it to?
Regeneron Pharmaceuticals (0R2M.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Walgreens Boots Alliance.
What is the forecast for Regeneron Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Regeneron Pharmaceuticals' stock price to be around $582.2 in 2026. Starting from the current price of $549.6, this represents a 5.9% change in price, indicating a bullish outlook for the stock.
How to buy Regeneron Pharmaceuticals (0R2M.L) Stock?
Regeneron Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Regeneron Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.